FDA Approves LURASIDONE HYDROCHLORIDE — Amneal Pharmaceuticals LLC

# Amneal Pharmaceuticals Receives FDA Approval for Generic Lurasidone Hydrochloride Amneal Pharmaceuticals LLC has received FDA approval for its generic oral formulation of lurasidone hydrochloride, an atypical antipsychotic, potentially capturing significant market share from the branded Latuda as patent protections erode. The approval positions Amneal to compete in the growing mental health medication market while offering cost-effective treatment alternatives to patients and payers.